New study of SEER data below [1].
"Relative to white patients, an important cancer-specific mortality advantage applies to intermediate-risk and high-risk Asian prostate cancer patients treated with external beam radiotherapy, and to high-risk Asian patients treated with radical prostatectomy. These observations should be considered in pretreatment risk stratification and decision-making."
...
CSM (cancer-specific mortality)
"In high-risk EBRT-treated Asian versus white patients (Fig. 1), respective 10-year CSM rates were 10.4% versus 13.4%, which resulted in a multivariable CRR HR of 0.70 (P < 0.001), showing a decreased risk for Asian patients (Table 2). In intermediate-risk EBRT-treated Asian versus white patients, 10-year CSM rates were 3.0% versus 4.9%, which resulted in a multivariable CRR HR of 0.58 (P < 0.001), showing a decreased risk for Asian patients. In high-risk RP-treated Asian versus white patients, 10-year CSM rates were 4.8% versus 6.7%, which resulted in a multivariable CRR HR of 0.72 (P = 0.04), showing a decreased risk for Asian patients. Conversely, no statistically significant CSM differences were recorded between Asian and white patients in intermediate-risk RP-treated patients"
...
OCM (other-cause mortality)
"In RP patients, Asian patients showed the lowest 10-year OCM rates (7.4%), versus 8.0, 8.4 and 11.2% in Hispanic/Latino, white and African American patients, respectively. Finally, in EBRT patients, Asian patients showed the second lowest 10-year OCM rates (24.1%), after Hispanic/Latino patients (23.1%), versus 10-year OCM rates of 29.0% and 28.3% in white and African American patients, respectively."
-Patrick
[1] Full text: onlinelibrary.wiley.com/doi...
pubmed.ncbi.nlm.nih.gov/345...
Int J Urol
. 2022 Jan;29(1):17-24. doi: 10.1111/iju.14701. Epub 2021 Sep 22.
External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients
Christoph Würnschimmel 1 2 , Mike Wenzel 2 3 , Francesco Chierigo 4 , Rocco Simone Flammia 5 , Zhe Tian 2 , Fred Saad 2 , Alberto Briganti 6 , Shahrokh F Shariat 7 8 9 10 11 12 , Nazareno Suardi 4 , Carlo Terrone 4 , Michele Gallucci 5 , Felix Kh Chun 3 , Derya Tilki 1 13 , Markus Graefen 1 , Pierre I Karakiewicz 2
Affiliations expand
PMID: 34553428 DOI: 10.1111/iju.14701
Abstract
Objectives: To test the effect of race/ethnicity on cancer-specific mortality after radical prostatectomy or external beam radiotherapy in localized prostate cancer patients.
Methods: In the Surveillance, Epidemiology and End Results database 2004-2016, we identified intermediate-risk and high-risk white (n = 151 632), Asian (n = 11 189), Hispanic/Latino (n = 20 077) and African American (n = 32 550) localized prostate cancer patients, treated with external beam radiotherapy or radical prostatectomy. Race/ethnicity-stratified cancer-specific mortality analyses relied on competing risks regression, after propensity score matching for patient and cancer characteristics.
Results: Compared with white patients, Asian intermediate- and high-risk external beam radiotherapy patients showed lower cancer-specific mortality (hazard ratio 0.58 and 0.70, respectively, both P ≤ 0.02). Additionally, Asian high-risk radical prostatectomy patients also showed lower cancer-specific mortality than white patients (hazard ratio 0.72, P = 0.04), but not Asian intermediate-risk radical prostatectomy patients (P = 0.08). Conversely, compared with white patients, African American intermediate-risk radical prostatectomy patients showed higher cancer-specific mortality (hazard ratio 1.36, P = 0.01), but not African American high-risk radical prostatectomy or intermediate- and high-risk external beam radiotherapy patients (all P ≥ 0.2). Finally, compared with white people, no cancer-specific mortality differences were recorded for Hispanic/Latino patients after external beam radiotherapy or radical prostatectomy, in both risk levels (P ≥ 0.2).
Conclusions: Relative to white patients, an important cancer-specific mortality advantage applies to intermediate-risk and high-risk Asian prostate cancer patients treated with external beam radiotherapy, and to high-risk Asian patients treated with radical prostatectomy. These observations should be considered in pretreatment risk stratification and decision-making.
Keywords: Epidemiology and End Results; Surveillance; cancer-specific mortality; external beam radiotherapy; localized prostate cancer; other-cause mortality; radical prostatectomy.
© 2021 The Authors. International Journal of Urology published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association.